(Q50974260)

English

Intratumor OX40 stimulation inhibits IRF1 expression and IL-10 production by Treg cells while enhancing CD40L expression by effector memory T cells.

scientific article published in December 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/22229156

Intratumor OX40 stimulation inhibits IRF1 expression and IL-10 production by Treg cells while enhancing CD40L expression by effector memory T cells. (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/22229156

Alessia Burocchi

1

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/22229156

Mario Paolo Colombo

4

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/22229156

author name string

Paola Pittoni

2

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/22229156

Andrea Gorzanelli

3

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/22229156

Silvia Piconese

5

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/22229156

language of work or name

0 references

publication date

1 December 2011

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/22229156

European Journal of Immunology

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/22229156

41

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/22229156

12

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/22229156

3615-3626

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/22229156

Cancer despite immunosurveillance: immunoselection and immunosubversion

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141700

21 January 2018

How regulatory T cells work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141700

21 January 2018

OX40 triggering blocks suppression by regulatory T cells and facilitates tumor rejection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141700

21 January 2018

OX40 costimulation turns off Foxp3+ Tregs.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141700

21 January 2018

OX40 ligand shuts down IL-10-producing regulatory T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141700

21 January 2018

OX40-OX40 ligand interaction in T-cell-mediated immunity and immunopathology.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141700

21 January 2018

Control of immunity by the TNFR-related molecule OX40 (CD134)

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141700

21 January 2018

OX40/OX40L costimulation affects induction of Foxp3+ regulatory T cells in part by expanding memory T cells in vivo

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141700

21 January 2018

Activation of NF-kappaB1 by OX40 contributes to antigen-driven T cell expansion and survival

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141700

21 January 2018

OX40 promotes Bcl-xL and Bcl-2 expression and is essential for long-term survival of CD4 T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141700

21 January 2018

The regulation of IL-10 production by immune cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141700

21 January 2018

Heterogeneity of CD4+ memory T cells: functional modules for tailored immunity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141700

21 January 2018

CD40L+ CD4+ memory T cells migrate in a CD62P-dependent fashion into reactive lymph nodes and license dendritic cells for T cell priming

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141700

21 January 2018

A therapeutic OX40 agonist dynamically alters dendritic, endothelial, and T cell subsets within the established tumor microenvironment.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141700

21 January 2018

OX40 agonist therapy enhances CD8 infiltration and decreases immune suppression in the tumor.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141700

21 January 2018

Nonredundant roles for B cell-derived IL-10 in immune counter-regulation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141700

21 January 2018

IFN-alpha induces the human IL-10 gene by recruiting both IFN regulatory factor 1 and Stat3.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141700

21 January 2018

Anthrax lethal toxin enhances TNF-induced endothelial VCAM-1 expression via an IFN regulatory factor-1-dependent mechanism

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141700

21 January 2018

IFN regulatory factor-1 bypasses IFN-mediated antiviral effects through viperin gene induction

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141700

21 January 2018

Molecular mechanism and function of CD40/CD40L engagement in the immune system.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141700

21 January 2018

Dendritic cells infiltrating tumors cotransduced with granulocyte/macrophage colony-stimulating factor (GM-CSF) and CD40 ligand genes take up and present endogenous tumor-associated antigens, and prime naive mice for a cytotoxic T lymphocyte respons

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141700

21 January 2018

Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141700

21 January 2018

Regulatory T cell lineage specification by the forkhead transcription factor foxp3

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141700

21 January 2018

Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141700

21 January 2018

T-regulatory cells shift from a protective anti-inflammatory to a cancer-promoting proinflammatory phenotype in polyposis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141700

21 January 2018

Interleukin-10: new perspectives on an old cytokine

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141700

21 January 2018

Reversal of tumor-induced dendritic cell paralysis by CpG immunostimulatory oligonucleotide and anti-interleukin 10 receptor antibody

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141700

21 January 2018

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141700

21 January 2018

Selective depletion of Foxp3+ regulatory T cells improves effective therapeutic vaccination against established melanoma

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141700

21 January 2018

Conditional regulatory T-cell depletion releases adaptive immunity preventing carcinogenesis and suppressing established tumor growth.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141700

21 January 2018

IL-10-secreting regulatory T cells do not express Foxp3 but have comparable regulatory function to naturally occurring CD4+CD25+ regulatory T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141700

21 January 2018

TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141700

21 January 2018

Cytomegalovirus exploits IL-10-mediated immune regulation in the salivary glands

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141700

21 January 2018

Genomic definition of multiple ex vivo regulatory T cell subphenotypes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141700

21 January 2018

Distinct inflammatory signals have physiologically divergent effects on epigenetic regulation of Foxp3 expression and Treg function.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141700

21 January 2018

Hybrid Treg cells: steel frames and plastic exteriors

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141700

21 January 2018

The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141700

21 January 2018

Function of miR-146a in controlling Treg cell-mediated regulation of Th1 responses

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141700

21 January 2018

Foxp3+ regulatory T cells: differentiation, specification, subphenotypes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141700

21 January 2018

Plasticity of CD4(+) FoxP3(+) T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141700

21 January 2018

Developmental plasticity of Foxp3+ regulatory T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141700

21 January 2018

Reprogrammed foxp3(+) regulatory T cells provide essential help to support cross-presentation and CD8(+) T cell priming in naive mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141700

21 January 2018

Triggering of OX40 (CD134) on CD4(+)CD25+ T cells blocks their inhibitory activity: a novel regulatory role for OX40 and its comparison with GITR.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141700

21 January 2018

Cutting Edge: OX40 agonists can drive regulatory T cell expansion if the cytokine milieu is right

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141700

21 January 2018

IFN-inducible GTPases and immunity to intracellular pathogens

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141700

21 January 2018

OX40 is required for regulatory T cell-mediated control of colitis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141700

21 January 2018

Antigen-independent signalosome of CARMA1, PKCθ, and TNF receptor-associated factor 2 (TRAF2) determines NF-κB signaling in T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141700

21 January 2018

The TRAIL to selective tumor death

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141700

21 January 2018

OX40 ligand-transduced tumor cell vaccine synergizes with GM-CSF and requires CD40-Apc signaling to boost the host T cell antitumor response

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141700

21 January 2018

CD40 activation in vivo overcomes peptide-induced peripheral cytotoxic T-lymphocyte tolerance and augments anti-tumor vaccine efficacy

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141700

21 January 2018

Cutting edge: OX40 inhibits TGF-beta- and antigen-driven conversion of naive CD4 T cells into CD25+Foxp3+ T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141700

7 January 2021

based on heuristic

inferred from DOI database lookup

Engagement of the OX-40 receptor in vivo enhances antitumor immunity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141700

7 January 2021

based on heuristic

inferred from DOI database lookup

Distinct and overlapping roles of interleukin-10 and CD25+ regulatory T cells in the inhibition of antitumor CD8 T-cell responses

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141700

7 January 2021

based on heuristic

inferred from DOI database lookup

Characterization of Foxp3+CD4+CD25+ and IL-10-Secreting CD4+CD25+ T Cells during Cure of Colitis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141700

7 January 2021

based on heuristic

inferred from DOI database lookup

Differential CD40/CD40L expression results in counteracting antitumor immune responses

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141700

7 January 2021

based on heuristic

inferred from DOI database lookup

Suppression of mature dendritic cell function by regulatory T cells in vivo is abrogated by CD40 licensing

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141700

7 January 2021

based on heuristic

inferred from DOI database lookup

Regulatory T cells expressing interleukin 10 develop from Foxp3+ and Foxp3- precursor cells in the absence of interleukin 10

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141700

7 January 2021

based on heuristic

inferred from DOI database lookup

Redirecting in vivo elicited tumor infiltrating macrophages and dendritic cells towards tumor rejection.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141700

7 January 2021

based on heuristic

inferred from DOI database lookup

A unique subset of CD4+CD25highFoxp3+ T cells secreting interleukin-10 and transforming growth factor-beta1 mediates suppression in the tumor microenvironment

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141700

7 January 2021

based on heuristic

inferred from DOI database lookup

The contribution of transcription factor IRF1 to the interferon-gamma-interleukin 12 signaling axis and TH1 versus TH-17 differentiation of CD4+ T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141700

7 January 2021

based on heuristic

inferred from DOI database lookup

A non-redundant role for OX40 in the competitive fitness of Treg in response to IL-2

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141700

7 January 2021

based on heuristic

inferred from DOI database lookup

OX40 is differentially expressed on activated rat and mouse T cells and is the sole receptor for the OX40 ligand

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141700

7 January 2021

based on heuristic

inferred from DOI database lookup

Regulation of transcriptional activity of the murine CD40 ligand promoter in response to signals through TCR and the costimulatory molecules CD28 and CD2

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141700

7 January 2021

based on heuristic

inferred from DOI database lookup

Conversion of tumor-specific CD4+ T-cell tolerance to T-cell priming through in vivo ligation of CD40

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141700

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/EJI.201141700

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/22229156

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/22229156

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50974260&oldid=1447401624"